Literature DB >> 1554841

Meningococcal meningitis in sub-Saharan Africa: a model for the epidemic process.

P S Moore1.   

Abstract

Epidemic group A meningococcal meningitis follows a unique and distinctive pattern in sub-Saharan Africa. Advances in molecular and field epidemiology have begun to elucidate the mechanisms of meningococcal meningitis epidemics. Epidemics result from a complex combination of host, organism, and environmental risk factors. Recent studies suggest that "antigenic shifts" in group A meningococcal clones may trigger an outbreak of disease by suddenly decreasing herd immunity within a population. Although the introduction of new group A meningococcal strains into a susceptible population contributes to the likelihood of an epidemic, the presence of additional environmental factors, such as low humidity and coincident respiratory tract infections, are also necessary for an epidemic to occur. Despite the unique behavior of group A meningococcal disease in sub-Saharan Africa, the application of similar methods of epidemiological analysis may be useful for determining epidemic processes for other diseases.

Entities:  

Mesh:

Year:  1992        PMID: 1554841     DOI: 10.1093/clinids/14.2.515

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  37 in total

1.  Maternal cigarette smoking and invasive meningococcal disease: a cohort study among young children in metropolitan Atlanta, 1989-1996.

Authors:  H R Yusuf; R W Rochat; W S Baughman; P M Gargiullo; B A Perkins; M D Brantley; D S Stephens
Journal:  Am J Public Health       Date:  1999-05       Impact factor: 9.308

2.  Induction of a protective capsular polysaccharide antibody response to a multiepitope DNA vaccine encoding a peptide mimic of meningococcal serogroup C capsular polysaccharide.

Authors:  Deborah M Prinz; S Louise Smithson; Thomas Kieber-Emmons; M A Julie Westerink
Journal:  Immunology       Date:  2003-10       Impact factor: 7.397

3.  A human disease indicator for the effects of recent global climate change.

Authors:  Jonathan A Patz
Journal:  Proc Natl Acad Sci U S A       Date:  2002-09-23       Impact factor: 11.205

Review 4.  Epidemiology, diagnosis, and antimicrobial treatment of acute bacterial meningitis.

Authors:  Matthijs C Brouwer; Allan R Tunkel; Diederik van de Beek
Journal:  Clin Microbiol Rev       Date:  2010-07       Impact factor: 26.132

5.  Spatial dynamics of meningococcal meningitis in Niger: observed patterns in comparison with measles.

Authors:  N Bharti; H Broutin; R F Grais; M J Ferrari; A Djibo; A J Tatem; B T Grenfell
Journal:  Epidemiol Infect       Date:  2011-10-05       Impact factor: 2.451

6.  Use of ceftriaxone during epidemics in patients with suspected meningococcal meningitis.

Authors:  Allan R Tunkel
Journal:  Curr Infect Dis Rep       Date:  2006-06       Impact factor: 3.725

Review 7.  Prospects for vaccine prevention of meningococcal infection.

Authors:  Lee H Harrison
Journal:  Clin Microbiol Rev       Date:  2006-01       Impact factor: 26.132

8.  Molecular epidemiology of neisseria meningitidis isolated in the African Meningitis Belt between 1988 and 2003 shows dominance of sequence type 5 (ST-5) and ST-11 complexes.

Authors:  Pierre Nicolas; Gunnstein Norheim; Eric Garnotel; Saacou Djibo; Dominique A Caugant
Journal:  J Clin Microbiol       Date:  2005-10       Impact factor: 5.948

9.  Priority during a meningitis epidemic: vaccination or treatment?

Authors:  H Veeken; K Ritmeijer; B Hausman
Journal:  Bull World Health Organ       Date:  1998       Impact factor: 9.408

10.  Seasonality of meningitis in Africa and climate forcing: aerosols stand out.

Authors:  L Agier; A Deroubaix; N Martiny; P Yaka; A Djibo; H Broutin
Journal:  J R Soc Interface       Date:  2012-12-05       Impact factor: 4.118

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.